Published Guidance, NICE advice and quality standards

Skip to filtersSkip to results

Skip to results

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 176 to 200 of 2379

TitleReference numberPublishedLast updated
Oesophago-gastric cancer: assessment and management in adultsNG83
Depression in adultsQS8
Botulinum toxin type A injections into the urethral sphincter for idiopathic chronic non-obstructive urinary retentionIPG766
Radiofrequency denervation for osteoarthritic knee painIPG767
Deucravacitinib for treating moderate to severe plaque psoriasisTA907
Endoscopic ultrasound-guided gallbladder drainage for acute cholecystitis when surgery is not an optionIPG764
Minimally invasive fusionless posterior-approach surgery to correct idiopathic scoliosis in children and young peopleIPG765
Dapagliflozin for treating chronic heart failure with preserved or mildly reduced ejection fractionTA902
Darolutamide with androgen deprivation therapy and docetaxel for treating hormone-sensitive metastatic prostate cancerTA903
Pembrolizumab with lenvatinib for previously treated advanced or recurrent endometrial cancerTA904
Upadacitinib for previously treated moderately to severely active Crohn's diseaseTA905
MiraQ cardiac TTFM with high-frequency probe for assessing graft flow during coronary artery bypass graft surgeryMIB323
Cemiplimab for treating recurrent or metastatic cervical cancer (terminated appraisal)TA901
Dabrafenib plus trametinib for treating BRAF V600 mutation-positive advanced non-small-cell lung cancerTA898
Tixagevimab plus cilgavimab for preventing COVID-19TA900
YOURmeds for medication support in long-term conditionsMIB289
FibroScan for assessing liver fibrosis and cirrhosis outside secondary and specialist careDG48
Atopic eczema in under 12s: diagnosis and managementCG57
Axicabtagene ciloleucel for treating relapsed or refractory follicular lymphomaTA894
Axicabtagene ciloleucel for treating relapsed or refractory diffuse large B-cell lymphoma after first-line chemoimmunotherapyTA895
Bulevirtide for treating chronic hepatitis DTA896
Brexucabtagene autoleucel for treating relapsed or refractory B-cell acute lymphoblastic leukaemia in people 26 years and overTA893
Intraoperative electron beam radiotherapy for locally advanced and locally recurrent colorectal cancerIPG763
Proov Confirm for ovulation confirmationMIB322
Daratumumab with bortezomib and dexamethasone for previously treated multiple myelomaTA897

Results per page

  1. 10
  2. 25
  3. 50
  4. All